Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Deloitte
Moodys
Johnson and Johnson
AstraZeneca
Harvard Business School
Teva
Citi
Boehringer Ingelheim
Baxter

Generated: January 23, 2018

DrugPatentWatch Database Preview

BUTAZOLIDIN Drug Profile

« Back to Dashboard

When do Butazolidin patents expire, and what generic alternatives are available?

Butazolidin is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in BUTAZOLIDIN is phenylbutazone. There are nine drug master file entries for this compound. Additional details are available on the phenylbutazone profile page.
Drug patent expirations by year for BUTAZOLIDIN
Medical Subject Heading (MeSH) Categories for BUTAZOLIDIN

US Patents and Regulatory Information for BUTAZOLIDIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis BUTAZOLIDIN phenylbutazone CAPSULE;ORAL 008319-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis BUTAZOLIDIN phenylbutazone TABLET;ORAL 008319-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Farmers Insurance
UBS
Mallinckrodt
Daiichi Sankyo
US Army
Express Scripts
Teva
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot